https://www.bloomberg.com/news/articles/2019-11-15/fda-approves-first-chinese-cancer-drug-for-u-s-patient-use
https://www.chinadaily.com.cn/a/201911/20/WS5dd44b67a310cf3e35578843.html
The drug, known as Brukinsa, is a product from Beijing-based BeiGene. It received the FDA's approval on Friday and will probably become available to US patients by the end of the year, Wu Xiaobin, BeiGene president, said at a news conference on Friday. (2019-11-20)
